First drug proves able to improve survival from COVID-19, trial shows
A steroid called dexamethasone reduced deaths by up to one third in severely ill hospitalised patients, according to UK-led clinical study.
Full Article
First drug proves able to improve survival from COVID-19, trial shows
Sydney Morning Herald
0 shares
1 views
You might like
Related news coverage
11 critical questions about the coronavirus that remain unanswered, 6 months after the first cases were reported
Business Insider
· Experts continue to study the coronavirus as the number of people it infects and kills rises each day.
· Scientists are..
-
NA Proactive news snapshot: Milestone Scientific, BetterLife Pharma, Revive Therapeutics, Matinas BioPharma, Biocept UPDATE …
Proactive Investors
-
NA Proactive news snapshot: Biocept, Globex Mining Enterprises, Q BioMed, ImagineAR UPDATE …
Proactive Investors
-
Q BioMed expects sales revenue from Strontium89 this quarter as it updates shareholders
Proactive Investors
-
NA Proactive news snapshot: OTC Markets Group, NetCents Technology, EuroLife Brands, Pacton Gold, Tectonic Metals, Group Eleven Resources UPDATE ...
Proactive Investors
Advertisement
More coverage
US Measures Weaken Slow But Sure Growth Of World Law – OpEd
Eurasia Review
President Donald Trump’s executive order of 11 June 2020 proposing sanctions against staff and family members of the..
-
NA Proactive news snapshot: NexTech AR, EnWave Corporation, GlobeX Data, Acasti Pharma UPDATE ...
Proactive Investors
-
Acasti Pharma eyeing TRILOGY 2 data as it reveals phenomenon of 'triglyceride normalization' could have played part in first trial
Proactive Investors
-
NA Proactive news snapshot: CytoDyn, CanaFarma Hemp Products Corp, XPhyto Therapeutics, NetCents Technology …
Proactive Investors
-
Canada’s surprising history and questionable partnership with a Chinese company and its military-backed COVID-19 vaccine
National Post